DE19757765A1 - Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung - Google Patents

Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung

Info

Publication number
DE19757765A1
DE19757765A1 DE19757765A DE19757765A DE19757765A1 DE 19757765 A1 DE19757765 A1 DE 19757765A1 DE 19757765 A DE19757765 A DE 19757765A DE 19757765 A DE19757765 A DE 19757765A DE 19757765 A1 DE19757765 A1 DE 19757765A1
Authority
DE
Germany
Prior art keywords
vzv
nucleic acid
immunoreactive
antibodies
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19757765A
Other languages
German (de)
English (en)
Inventor
Markus Dr Eickmann
Dorothee Gicklhorn
Klaus Prof Dr Radsak
Hans-Peter Dr Hauser
Bernhard Dr Giesendorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Priority to DE19757765A priority Critical patent/DE19757765A1/de
Priority to ES98122350T priority patent/ES2229435T3/es
Priority to DE1998512115 priority patent/DE59812115D1/de
Priority to AT98122350T priority patent/ATE279520T1/de
Priority to EP98122350A priority patent/EP0927759B1/de
Priority to CA002255106A priority patent/CA2255106C/en
Priority to JP36493498A priority patent/JP4532614B2/ja
Priority to US09/219,337 priority patent/US6258363B1/en
Publication of DE19757765A1 publication Critical patent/DE19757765A1/de
Priority to US09/874,140 priority patent/US7135186B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19757765A 1997-12-23 1997-12-23 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung Withdrawn DE19757765A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19757765A DE19757765A1 (de) 1997-12-23 1997-12-23 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung
ES98122350T ES2229435T3 (es) 1997-12-23 1998-11-25 Proteina vp26 inmunorreactiva del virus varicella zoster (vzv) y su uso en diagnostico.
DE1998512115 DE59812115D1 (de) 1997-12-23 1998-11-25 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung
AT98122350T ATE279520T1 (de) 1997-12-23 1998-11-25 Immunreaktives protein vp26 des varicella-zoster- virus (vzv) und seine diagnostische verwendung
EP98122350A EP0927759B1 (de) 1997-12-23 1998-11-25 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung
CA002255106A CA2255106C (en) 1997-12-23 1998-12-16 Varicella zoster virus (vzv) immunoreactive protein vp26 and its diagnostic use
JP36493498A JP4532614B2 (ja) 1997-12-23 1998-12-22 水痘帯状疱疹ウイルス（ｖｚｖ）免疫反応性タンパク質ｖｐ２６およびその診断的使用
US09/219,337 US6258363B1 (en) 1997-12-23 1998-12-23 Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
US09/874,140 US7135186B2 (en) 1997-12-23 2001-06-06 Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757765A DE19757765A1 (de) 1997-12-23 1997-12-23 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung

Publications (1)

Publication Number Publication Date
DE19757765A1 true DE19757765A1 (de) 1999-06-24

Family

ID=7853317

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19757765A Withdrawn DE19757765A1 (de) 1997-12-23 1997-12-23 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung
DE1998512115 Expired - Lifetime DE59812115D1 (de) 1997-12-23 1998-11-25 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1998512115 Expired - Lifetime DE59812115D1 (de) 1997-12-23 1998-11-25 Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung

Country Status (7)

Country Link
US (2) US6258363B1 (enExample)
EP (1) EP0927759B1 (enExample)
JP (1) JP4532614B2 (enExample)
AT (1) ATE279520T1 (enExample)
CA (1) CA2255106C (enExample)
DE (2) DE19757765A1 (enExample)
ES (1) ES2229435T3 (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus

Also Published As

Publication number Publication date
ATE279520T1 (de) 2004-10-15
EP0927759B1 (de) 2004-10-13
JPH11243974A (ja) 1999-09-14
CA2255106A1 (en) 1999-06-23
CA2255106C (en) 2010-01-12
US6258363B1 (en) 2001-07-10
EP0927759A3 (de) 1999-07-28
EP0927759A2 (de) 1999-07-07
ES2229435T3 (es) 2005-04-16
US7135186B2 (en) 2006-11-14
JP4532614B2 (ja) 2010-08-25
US20050202413A1 (en) 2005-09-15
DE59812115D1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
DE3882522T2 (de) Baculovirus-Transfervektoren.
DE69334191T2 (de) Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente
DE69230812T2 (de) Verfahren zum Nachweis einer Rinderdiarrhoe- virusinfektion, für ein durch eine Infektion mit diesem Virus induziertes Eiweiss kodierende Nukleotidsequenz, sowie daraus abgeleitete rekombinante Eiweisse und Antigene
DE69734387T2 (de) Ein kombiniertes antigen vom menschlichen cytomegalievirus und seine anwendung
DE69111880T2 (de) Immunogenes Protein und cDNA-Klon.
EP0252531B1 (de) Strukturelles Phosphoprotein (pp 150) des menschlichen Cytomegalovirus, seine Herstellung und Verwendung
DE69614393T2 (de) Herpes simplex viren diagnostik
DE4003826A1 (de) Immunologisch aktive peptide des parvovirus b19
EP0252302A1 (de) Hauptglykoprotein des menschlichen Cytomegalovirus, seine Herstellung und Verwendung
DE69130562T2 (de) Verbesserung in zusammenhang mit dem nachweis von viren
EP0927759B1 (de) Immunreaktives Protein VP26 des Varicella-Zoster-Virus (VZV) und seine diagnostische Verwendung
DE69930960T2 (de) Synthetische virus-ähnliche partikel mit heterologen epitopen.
DE19757767A1 (de) Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
DE69232975T2 (de) Protein p100von menschlichem Herpesvirus Typ 6, die korrespondierenden DNS Squenzen, ihre Herstellung und Verwendung
EP1594890B1 (de) Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
EP0547446B1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
EP0754755B1 (de) Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
DE69925911T2 (de) Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen
EP0893504A1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
DE69720470T2 (de) Western blot test zur identifizierung von hcmv spezifische antiköpern
EP0926155A2 (de) Polypeptide mit Aminosäuresequenzen aus dem N-terminalen Bereich von gp116 von Cytomegalovirus und deren Verwendung bei der Diagnostik, Prophylaxe und Therapie
DE4419294A1 (de) Ein 29 kD großes Membranprotein von Legionella pneumophila sowie dessen Nukleinsäuresequenz und die Verwendung in Diagnostik und Therapie
WO2000034472A1 (de) Spermatogenese-protein
WO1994003605A2 (en) Compositions and methods for detecting human herpesvirus 6 strain z29

Legal Events

Date Code Title Description
8141 Disposal/no request for examination